Rubinstein, Jack http://orcid.org/0000-0002-8811-1551
Robbins, Nathan
Evans, Karen
Foster, Gabrielle
Mcconeghy, Kevin
Onadeko, Toluwalope
Bunke, Julie
Parent, Melanie
Luo, Xi
Joseph, Jacob
Wu, Wen-Chih
Funding for this research was provided by:
Office of Academic Affiliations, Department of Veterans Affairs (I01 CX001968)
Article History
Received: 7 June 2021
Accepted: 26 March 2022
First Online: 7 April 2022
Declarations
:
: Ethical approval has been granted by the VA central IRB as well as the relevant ethics committee at each institution where the study will be performed. A statement confirming informed consent will be obtained from all study participants.
: Not applicable.
: Dr Rubinstein is a founding member of TRP therapeutics and has not received any fees, salary, or honoraria from this venture. He is also a founding member and board member of CinTRYP LLC from which he is currently defunct, in the past he received honoraria and royalties. He will not have access to the study data at any point prior to unblinding. All other authors have no disclosures to note.